Indefinite Delivery Contract 36C24925D0012
Award Date
10/1/24
Last Date to Order
9/30/29
Federal Agency
Veterans Integrated Service Network 9
Awardee
Pharmalogic Holdings Corp.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key products and services being delivered under this federal contract Indefinite Delivery Vehicle (IDV) award are radiopharmaceuticals, specifically F-18 PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., a for-profit pharmaceutical company specializing in innovative diagnostic imaging agents. The $5,990,475.20 Indefinite...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an indefinite-delivery contract to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, to provide single dose radiopharmaceuticals in support of nuclear medicine services. Over the period of performance from March 2020 to February 2025, the contract established a total potential value of $2,664,954.52. Delivery orders issued against this contract vehicle from 2020...
This Blanket Purchase Agreement (BPA) contract with a ceiling value of $978,250.00 was awarded by the U.S. Department of Veterans Affairs (VA) to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico), a for-profit corporate entity. The contract is for the supply of F18-Florbetapir (NeuraCeq) radiopharmaceutical unit doses to support nuclear medicine diagnostic imaging procedures at VA medical facilities. The contract is a single-award BPA structured as a delivery order with a...
The key products and services being delivered under this federal contract IDV award are radiopharmaceutical diagnostic imaging agents, specifically PYLARIFY (piflufolastat F-18), provided by Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The Department of Veterans Affairs (VA) is the primary funding agency for this single-award Indefinite Delivery Contract, valued at $5,052,208 with a period of performance through January 31, 2030. Task orders issued under this IDV...
The key products and services being delivered under this Blanket Purchase Agreement (BPA) federal contract Indefinite Delivery Vehicle (IDV) are PYLARIFY (piflufolastat F-18), a radiopharmaceutical drug used for positron emission tomography (PET) imaging of prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and a subsidiary of Lantheus Holdings, Inc. The contract, valued at up to $1,188,615.44, was awarded by the U.S....
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the provision of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The single-award BPA, valued at $2,634,365.60, was established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has...
The key products and services being delivered under this federal contract IDV are PYLARIFY (piflufolastat F-18), a radiopharmaceutical drug used for positron emission tomography (PET) imaging of prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and a subsidiary of Lantheus Holdings, Inc. The contract vehicles include several Blanket Purchase Agreements (BPAs) awarded by the U.S. Department of Veterans Affairs (VA) and the...
The U.S. Department of Veterans Affairs (VA) has awarded Blanket Purchase Agreements (BPAs) totaling over $4.3 million to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the delivery of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used in positron emission tomography (PET) scans to detect prostate cancer. These BPAs, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allow various VA healthcare facilities across the Veterans...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $2,345,668 Firm Fixed Price contract has an ultimate completion date of August 31, 2029 and was awarded on September 1, 2024. The contract is for the delivery of PYLARIFY (piflufolastat F-18) isotopes, which are used for prostate cancer detection through positron emission...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded an indefinite delivery contract to Pharmalogic WV LTD for the delivery of radiopharmaceutical products and services in support of nuclear medicine programs serving veterans. The base contract value is $388,738.36 for the period of October 1, 2020 through March 31, 2024. Four task orders were subsequently issued against the contract with values ranging from $265,884.10 to $900,000.00...